Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers

Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers

Introduction: The fourth SARS-CoV-2 vaccine dose was found to protect against infection and more importantly against severe disease and death. It was also shown that the risk of symptomatic or severe disease was related to the antibody levels after vaccination or infection, with lower protection aga...

Full description

Bibliographic Details
Main Authors: Yael Shachor-Meyouhas, Halima Dabaja-Younis, Avi Magid, Ronit Leiba, Moran Szwarcwort-Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Nethanel A. Horowitz, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Khetam Hussein
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Vaccines
Subjects:
COVID-19
Immunogenicity
serology
health care workers
booster
Online Access:https://www.mdpi.com/2076-393X/11/2/283

Similar Items

Similar Items